Select a site...
TWN - Biosafety Information Centre
TWN - Finance Information Centre
TWN - Main Site
TWN Indonesia
TWN Chinese
About Us
|
Contact
|
Sitemap
Home
All Publications
Log In
or
Register
Advanced Search
Your cart is empty
$ US Dollar
Currency:
English
echo HEADER_LANGUAGES;?>
Browse TWN Books
International Trade
Finance & Economy
Intellectual Property Rights
Biotechnology/Biosafety
Biodiversity
Climate Change
Environment
Development
Health/Medical
Others
Browse TWN Series
Antimicrobial Resistance
Trade & Development
Global Economy
Intellectual Property Rights
Biodiversity, Knowledge & Rights
Biotechnology & Biosafety
Climate Change
Environment & Development
Gender
Important Links
Third World Resurgence
Third World Economics
South-North Development Monitor (SUNS)
Browse Books by Other Publishers
Other Publishers
Newsletter
Enter your email address to subscribe to our Newsletter.
HTML
TEXT-Only
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Site Map
Discount Coupons
Home
::
Browse TWN Series
::
Intellectual Property Rights
:: Imports by and Exports to Countries with Insufficient or No Manufacturing Capacities in the Pharmaceutical Sector (No. 8)
Imports by and Exports to Countries with Insufficient or No Manufacturing Capacities in the Pharmaceutical Sector (No. 8)
Product 4/15
USD 6.00
Publisher:
TWN
ISBN:
983-2729-52-1
Year:
2005
No. of pages:
40
Size of book:
16.5cm x 24cm
Author:
TWN
About the Book
This TWN report is on the measures required by countries lacking drug manufacturing capacity and wishing to import generic drugs and measures required by countries able and willing to export generic drugs and wishing to overcome the constraints imposed by TRIPS Article 31(f) that production under compulsory licence has to be supplied predominantly for the domestic market. It is based on the Decision of 30 August 2003 adopted by the WTO General Council.
This report is a supplement updating the Manual on Good Practices in Public-Health-Sensitive Policy Measures and Patent Laws, published by the Third World Network.
Contents
Overcoming the TRIPS Restriction on Pharmaceutical Imports by and Exports to Countries with Insufficient Manufacturing Capacity
(a) Background to the "Paragraph 6" issue in the Doha Declaration on the TRIPS Agreement and Public Health
(b) Problem of countries with insufficient or no manufacturing capacities
(c) In search of a solution
(d) The Decision and Statement
Conditions and Measures for Implementing the Waiver to the TRIPS Restriction
(a) Countries and situations where the waiver is not required
(b) General situation where the waiver is required
(c) Measures required by the importing country
Measures Required by the Exporting Country
(a) Notify the WTO
(b) Conditions of the compulsory licence
(c) Payment of compensation
(d) Regional arrangements
Additional Requirements under the WTO General Council Chairperson's Statement
Comment on the 'Dampening Effect' of the Conditions and Procedures in the Decision and Chairperson's Statement
Limited Area of Applicability of the Decision
Conclusions
References
Annex 1
Annex 2
Annex 3
Annex 4
Add to Cart:
This product was added to our catalog on Monday 16 January, 2012.
|
Home
|
About Us
|
Contact
|
Sitemap
|
Copyright © 2011 Third World Network. All Rights Reserved